These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24715518)

  • 41. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.
    Moran LJ; Pasquali R; Teede HJ; Hoeger KM; Norman RJ
    Fertil Steril; 2009 Dec; 92(6):1966-82. PubMed ID: 19062007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comprehensive clinical management of polycystic ovary syndrome.
    Setji TL; Brown AJ
    Minerva Med; 2007 Jun; 98(3):175-89. PubMed ID: 17592439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polycystic ovary syndrome: a common but often unrecognized condition.
    Shannon M; Wang Y
    J Midwifery Womens Health; 2012; 57(3):221-30. PubMed ID: 22594862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dietary therapy in polycystic ovary syndrome.
    Moran LJ; Brinkworth GD; Norman RJ
    Semin Reprod Med; 2008 Jan; 26(1):85-92. PubMed ID: 18181086
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Endocrinological assessment, treatment and follow-up on polycystic ovary syndrome].
    Glintborg D; Rungby J; Eskildsen P; Hermann AP; Stecher CW; Andersen M;
    Ugeskr Laeger; 2010 Jan; 172(3):196-9. PubMed ID: 20089209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of the metabolic syndrome in women with a previous diagnosis of polycystic ovary syndrome: long-term follow-up.
    Hudecova M; Holte J; Olovsson M; Larsson A; Berne C; Sundstrom-Poromaa I
    Fertil Steril; 2011 Nov; 96(5):1271-4. PubMed ID: 21872228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women.
    Anaforoglu I; Algun E; Incecayir O; Ersoy K
    Metab Syndr Relat Disord; 2011 Oct; 9(5):375-80. PubMed ID: 21657888
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.
    March WA; Moore VM; Willson KJ; Phillips DI; Norman RJ; Davies MJ
    Hum Reprod; 2010 Feb; 25(2):544-51. PubMed ID: 19910321
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A twenty-first century research agenda for polycystic ovary syndrome.
    Legro RS; Azziz R; Giudice L
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):331-6. PubMed ID: 16772161
    [TBL] [Abstract][Full Text] [Related]  

  • 50. International standards and guidelines on education and training for the multi-disciplinary health response to major events that threaten the health status of a community.
    Seynaeve G; Archer F; Fisher J; Lueger-Schuster B; Rowlands A; Sellwood P; Vandevelde K; Zigoura A;
    Prehosp Disaster Med; 2004; 19(2):S17-30. PubMed ID: 15506258
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exercise for the treatment and management of overweight women with polycystic ovary syndrome: a review of the literature.
    Thomson RL; Buckley JD; Brinkworth GD
    Obes Rev; 2011 May; 12(5):e202-10. PubMed ID: 20546140
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers.
    Ching HL; Burke V; Stuckey BG
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):373-9. PubMed ID: 17302871
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polycystic ovary syndrome: update on diagnosis and treatment.
    Setji TL; Brown AJ
    Am J Med; 2014 Oct; 127(10):912-9. PubMed ID: 24859638
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin resistance syndrome and polycystic ovary syndrome: implications for diagnosis and treatment.
    Tan S; Hahn S; Janssen OE
    Panminerva Med; 2005 Dec; 47(4):211-7. PubMed ID: 16489320
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Closing evidence to practice gaps in emergency care: the Australian experience.
    Huckson S; Davies J
    Acad Emerg Med; 2007 Nov; 14(11):1058-63. PubMed ID: 17704351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exercise therapy in polycystic ovary syndrome.
    Hoeger KM
    Semin Reprod Med; 2008 Jan; 26(1):93-100. PubMed ID: 18181087
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnosis of polycystic ovary syndrome.
    Trivax B; Azziz R
    Clin Obstet Gynecol; 2007 Mar; 50(1):168-77. PubMed ID: 17304034
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PCOS in adolescents.
    Diamanti-Kandarakis E
    Best Pract Res Clin Obstet Gynaecol; 2010 Apr; 24(2):173-83. PubMed ID: 19932060
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
    Otto-Buczkowska E; Jarosz-Chobot P; Deja G
    Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.